Måndag 21 April | 06:23:09 Europe / Stockholm

Prenumeration

2025-04-17 13:30:00

Estimates compiled by Modular Finance on behalf of XVIVO Perfusion.

Number of contributors: 7 (all of which have been updated or confirmed before the report)

KPI (MSEK, unless otherwise specified)Q1 2025E
Net sales213
Organic growth in local currency (%)13.00
Gross profit159
EBITDA43.2
EBIT25.3
Net profit23.6
Earnings per share (SEK)0.75

XVIVO Perfusion’s Q1 report will be released on Thursday, 24 April 2025 at 07.30 CEST.